30 Top Doctors in China

Dr. Fan Daiming is a renowned gastroenterologist and academician of the Chinese Academy of Engineering. He serves as the director of the National Clinical Research Center for Digestive Diseases at Xijing Hospital in Xi'an.

Specializing in the treatment of gastrointestinal cancers and inflammatory bowel diseases, Dr. Fan has developed innovative endoscopic techniques for early cancer detection and minimally invasive treatments. His research on the gut microbiome has opened new avenues for treating digestive disorders.

Dr. Fan has published over 500 research papers and trained generations of gastroenterologists in China. He continues to see patients while leading national efforts to improve digestive health through early screening programs and public education initiatives.

Dr. Huang Xiaojun is a leading hematologist and director of the Peking University Institute of Hematology. He is recognized as one of China's foremost experts in hematopoietic stem cell transplantation.

Specializing in the treatment of leukemia and other blood disorders, Dr. Huang has developed innovative transplantation protocols that have significantly improved survival rates. His work on haploidentical transplants (using partially matched donors) has made this life-saving treatment accessible to many more patients.

Under Dr. Huang's leadership, Peking University People's Hospital has become one of the world's largest and most successful hematopoietic stem cell transplantation centers. He continues to practice while conducting groundbreaking research on graft-versus-host disease prevention and treatment.

Dr. Ge Junbo is a pioneer in interventional cardiology in China and director of Zhongshan Hospital's Cardiovascular Institute in Shanghai. He has performed over 10,000 interventional procedures throughout his career.

Specializing in complex coronary interventions, Dr. Ge has developed innovative techniques for treating chronic total occlusions and left main coronary artery disease. He was among the first in China to perform transcatheter aortic valve implantation (TAVI) procedures.

Dr. Ge has trained hundreds of interventional cardiologists through China's national training programs. He continues to practice while serving as president of the Asian Pacific Society of Interventional Cardiology and conducting research on next-generation interventional technologies.

Dr. Shen Hongbing is a leading oncologist and president of Nanjing Medical University. His groundbreaking work in cancer genomics has transformed our understanding of cancer susceptibility in Chinese populations.

Specializing in gastrointestinal cancers, Dr. Shen has identified numerous genetic markers that predict cancer risk and treatment response. His research has led to the development of targeted therapies for esophageal and gastric cancers that are particularly prevalent in China.

Dr. Shen continues to see patients while leading China's national efforts in precision oncology. He has established one of Asia's largest cancer biobanks and genomic databases, enabling research that is tailoring cancer prevention and treatment to individual genetic profiles.

Dr. Zhang Wei is a distinguished orthopedic surgeon and director of Shanghai Sixth People's Hospital's Orthopedic Department, one of China's premier centers for musculoskeletal treatment and research.

Specializing in joint preservation and reconstruction, Dr. Zhang has developed innovative surgical techniques for treating severe osteoarthritis and complex fractures. His work on microsurgical limb replantation has set international standards for success rates.

Dr. Zhang has trained generations of orthopedic surgeons through China's national training programs. He continues to perform complex surgeries while conducting research on tissue engineering approaches to bone and cartilage regeneration.

Dr. Li Ning is a renowned surgeon and director of the Liver Transplantation Center at Beijing Friendship Hospital. He has performed over 2,000 liver transplants throughout his career, making him one of China's most experienced transplant surgeons.

Specializing in living donor liver transplantation, Dr. Li has developed innovative techniques that have significantly reduced complications for both donors and recipients. His work on immune tolerance induction has improved long-term outcomes for transplant patients.

Dr. Li continues to perform complex transplant surgeries while leading China's national efforts to expand organ donation and transplantation services. He has trained hundreds of surgeons in advanced hepatobiliary and transplant techniques.

Dr. Wang Haibo is a leading pediatric surgeon and director of the Pediatric Surgery Department at Beijing Children's Hospital, China's largest pediatric medical center. He has dedicated his career to advancing surgical care for children.

Specializing in minimally invasive pediatric surgery, Dr. Wang has pioneered laparoscopic techniques for treating congenital anomalies in newborns and young children. His work has significantly reduced recovery times and improved outcomes for complex pediatric conditions.

Dr. Wang continues to perform surgeries while leading national efforts to standardize and improve pediatric surgical care across China. He has established training programs that have raised the quality of pediatric surgery in regional hospitals throughout the country.

Dr. Chen Zhu is a distinguished hematologist and former Minister of Health of China. He serves as president of the Chinese Academy of Sciences and has made groundbreaking contributions to the treatment of leukemia.

Specializing in acute promyelocytic leukemia (APL), Dr. Chen developed a combination therapy using arsenic trioxide and all-trans retinoic acid that has transformed APL from a fatal disease to one with cure rates exceeding 90%. This innovative approach has been adopted worldwide.

Dr. Chen continues to conduct research while advising on national health policy. His work has bridged traditional Chinese medicine and modern molecular medicine, creating new paradigms for drug development and disease treatment.

Dr. Han Yaling is a leading cardiologist and director of the General Hospital of Northern Theater Command in Shenyang. She has made significant contributions to interventional cardiology and cardiovascular disease prevention in China.

Specializing in complex coronary interventions, Dr. Han has developed innovative techniques for treating multivessel coronary disease and chronic total occlusions. Her research on antiplatelet therapies has influenced treatment guidelines throughout Asia.

Dr. Han continues to perform procedures while leading large-scale clinical trials investigating new approaches to cardiovascular disease management. She has been instrumental in establishing regional systems for rapid treatment of acute myocardial infarction across northern China.

Dr. Zhang Xu is a renowned plastic surgeon and director of the Plastic Surgery Hospital at the Chinese Academy of Medical Sciences. He has pioneered numerous reconstructive techniques for complex facial and hand injuries.

Specializing in microsurgical reconstruction, Dr. Zhang has developed innovative approaches to restoring form and function after traumatic injuries and cancer resections. His work on composite tissue allotransplantation has pushed the boundaries of what's possible in reconstructive surgery.

Dr. Zhang continues to perform complex reconstructions while conducting research on tissue engineering and regenerative medicine approaches. He has trained generations of plastic surgeons through China's national training programs.

Dr. Liang Wannian is a leading public health expert and executive vice dean of Tsinghua University's Vanke School of Public Health. He has played key roles in China's responses to multiple public health emergencies.

Specializing in disease control and prevention, Dr. Liang has developed frameworks for epidemic response that have been implemented nationwide. His work on SARS, H1N1 influenza, and COVID-19 has helped shape China's public health strategies.

Dr. Liang continues to advise the Chinese government while conducting research on health system resilience and emergency preparedness. He has been instrumental in strengthening China's disease surveillance and early warning systems.

Dr. Wang Yifang is a distinguished neurologist and director of the Neurology Department at Xuanwu Hospital in Beijing, one of China's premier centers for neurological care and research.

Specializing in movement disorders and neurodegenerative diseases, Dr. Wang has developed comprehensive treatment protocols for Parkinson's disease and Alzheimer's disease that are used throughout China. Her research on early biomarkers for neurodegeneration has opened new possibilities for early intervention.

Dr. Wang continues to see patients while leading national efforts to improve neurological care in community hospitals. She has established specialized clinics for rare neurological disorders that serve as referral centers for complex cases from across China.

Dr. Zheng Shusen is a renowned hepatobiliary surgeon and academician of the Chinese Academy of Engineering. He serves as director of the First Affiliated Hospital of Zhejiang University's Hepatobiliary Pancreatic Center.

Specializing in liver cancer surgery, Dr. Zheng has developed innovative techniques for complex liver resections that have improved survival rates while preserving liver function. His work on combined liver-kidney transplantation has made this life-saving procedure available to more patients.

Dr. Zheng continues to perform complex surgeries while conducting research on liver regeneration and transplantation immunology. He has trained hundreds of surgeons through China's national hepatobiliary surgery training programs.

Dr. Ma Wenbin is a leading ophthalmologist and director of Beijing Tongren Hospital's Ophthalmology Department, China's premier eye care institution. He has made significant contributions to the treatment of retinal diseases.

Specializing in vitreoretinal surgery, Dr. Ma has developed innovative techniques for treating complex retinal detachments and macular disorders. His research on myopia progression in Chinese children has informed national prevention strategies.

Dr. Ma continues to perform delicate eye surgeries while leading China's national efforts to eliminate avoidable blindness. He has established screening programs that have dramatically reduced rates of diabetic retinopathy complications.

Dr. Yu Xuezhong is a distinguished thoracic surgeon and director of Shanghai Chest Hospital's Thoracic Surgery Department. He has pioneered minimally invasive approaches to lung cancer surgery that have become standard practice in China.

Specializing in video-assisted thoracic surgery (VATS), Dr. Yu has developed techniques that allow for complete lung cancer resections through small incisions, significantly reducing patient recovery times. His work on early-stage lung cancer detection and treatment has improved survival rates.

Dr. Yu continues to perform complex thoracic surgeries while conducting research on lung cancer genomics and targeted therapies. He has trained hundreds of surgeons in minimally invasive thoracic techniques through China's national training programs.

Dr. Li Youping is a pioneer of evidence-based medicine in China and director of the Chinese Evidence-Based Medicine Center at Sichuan University. She has been instrumental in promoting scientific approaches to clinical decision-making.

Specializing in clinical epidemiology, Dr. Li has established China's first Cochrane Center and led the development of Chinese clinical practice guidelines based on rigorous evidence synthesis. Her work has transformed how medical research is conducted and applied in China.

Dr. Li continues to advise healthcare institutions while conducting research on knowledge translation and implementation science. She has trained thousands of clinicians and researchers in evidence-based medicine methodologies.

Dr. Zhang Yingqi is a leading endocrinologist and director of the Endocrinology Department at Peking Union Medical College Hospital, China's premier institution for endocrine care and research.

Specializing in diabetes and metabolic disorders, Dr. Zhang has developed comprehensive treatment protocols that are used throughout China. Her research on the genetic basis of type 2 diabetes in Chinese populations has led to more personalized treatment approaches.

Dr. Zhang continues to see patients while leading national efforts to improve diabetes prevention and management. She has established community-based screening programs that have helped identify prediabetes and enable early intervention.

Dr. Chen Jie is a renowned dermatologist and director of Huashan Hospital's Dermatology Department in Shanghai, one of China's busiest and most respected dermatology centers.

Specializing in autoimmune skin disorders and skin cancer, Dr. Chen has developed innovative treatment protocols for severe psoriasis and cutaneous lymphomas. Her research on the skin microbiome has opened new avenues for treating chronic skin conditions.

Dr. Chen continues to see patients while conducting research on next-generation biologics for inflammatory skin diseases. She has established specialized clinics for rare skin disorders that serve as referral centers for complex cases from across China.

Dr. Wu Fan is a leading infectious disease specialist and director of the Shanghai Public Health Clinical Center. He has played key roles in China's responses to multiple infectious disease outbreaks.

Specializing in emerging infectious diseases, Dr. Wu has developed diagnostic and treatment protocols for SARS, H7N9 influenza, and COVID-19 that have been adopted nationwide. His research on antiviral therapies has contributed to China's preparedness for pandemic threats.

Dr. Wu continues to see patients while conducting research on pathogen evolution and transmission dynamics. He advises the Chinese government on infectious disease control strategies and has strengthened Shanghai's public health emergency response capabilities.

Dr. Zhou Qiang is a distinguished urologist and director of West China Hospital's Urology Department in Chengdu, one of China's largest and most advanced urology centers.

Specializing in robotic and minimally invasive urologic surgery, Dr. Zhou has pioneered techniques for prostate cancer and kidney cancer that have become standard practices in China. His work on urinary diversion procedures has improved quality of life for bladder cancer patients.

Dr. Zhou continues to perform complex urologic surgeries while conducting research on precision medicine approaches to urologic cancers. He has trained hundreds of urologists through China's national training programs.

Dr. Liu Zhihong is a renowned nephrologist and director of the National Clinical Research Center for Kidney Diseases at Nanjing General Hospital. He has made significant contributions to the understanding and treatment of kidney diseases in China.

Specializing in glomerular diseases and kidney transplantation, Dr. Liu has developed treatment protocols that have improved outcomes for patients with severe kidney conditions. His research on IgA nephropathy, a particularly common form of kidney disease in Asia, has led to more effective therapies.

Dr. Liu continues to see patients while leading national efforts to improve kidney disease prevention and management. He has established screening programs that have helped identify early-stage chronic kidney disease in high-risk populations.

Dr. Xu Guanhua is a leading geriatrician and director of the Geriatrics Department at Peking University First Hospital. He has been at the forefront of addressing China's aging population challenges.

Specializing in comprehensive geriatric assessment and multimorbidity management, Dr. Xu has developed care models that maintain functional independence in older adults. His research on frailty prevention has informed national health policies for aging populations.

Dr. Xu continues to see patients while leading national efforts to improve geriatric care in community health centers. He has established training programs that have raised the quality of geriatric medicine practice across China.

Dr. Sun Yan is a pioneering oncologist and former director of the Cancer Hospital at the Chinese Academy of Medical Sciences. She has dedicated her career to advancing cancer treatment in China.

Specializing in gastrointestinal cancers, Dr. Sun has developed chemotherapy regimens that have become standard treatments in China. Her clinical trials have helped establish evidence-based approaches to cancer care tailored to Chinese populations.

Dr. Sun continues to see patients while mentoring the next generation of oncologists. Her work has been instrumental in establishing China's national cancer center network and improving access to quality cancer care throughout the country.

Dr. Zhu Tong is a leading environmental health expert and dean of Peking University's College of Environmental Sciences and Engineering. He has made significant contributions to understanding the health impacts of air pollution in China.

Specializing in the cardiopulmonary effects of air pollution, Dr. Zhu's research has directly informed China's air quality standards and pollution control policies. His work on pollution exposure assessment has improved our understanding of health risks in urban environments.

Dr. Zhu continues to conduct research while advising government agencies on environmental health policies. He has established interdisciplinary research programs that bridge environmental science and clinical medicine.

Dr. Jiang Guozheng is a master of traditional Chinese medicine (TCM) and director of the China Academy of Chinese Medical Sciences. He has dedicated his career to integrating TCM with modern medical practices.

Specializing in the treatment of chronic diseases, Dr. Jiang has developed TCM protocols for diabetes, hypertension, and autoimmune disorders that are used in hospitals throughout China. His research on the pharmacological mechanisms of herbal medicines has bridged traditional knowledge and modern science.

Dr. Jiang continues to practice while leading national efforts to standardize and modernize TCM education and practice. He has been instrumental in establishing evidence-based approaches to evaluating TCM therapies and integrating them with conventional medical treatments.